Clinical Trial: A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Safety and Immunogenicity Study of 2 Formulations of GSK Biologicals' Varicella Vaccines Given as a 2-dose Course in the Second Year of Life.

Brief Summary: The purpose of this study is to evaluate the safety and immunogenicity of 2 formulations of GSK Biologicals' varicella vaccines given as a 2-dose course in the second year of life.

Hi there! I am WebHealthAI, I can help doctors enhance their practice by providing rapid access to medical information, aiding in clinical documentation, and supporting diagnostic decisions..

Be assured your chat is confidential and will not be shared.

A Network Connecting 2,812,626 Healthcare Professionals

Log In

Clinical Trial: A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.

WebHealth AI Chat